Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 22 Dec 2022

PLK4 initiates crosstalk between cell cycle, cell proliferation and macrophages infiltration in gliomas

in Cancer Immunity and Immunotherapy

Xiaoyang Zhang
Zesheng Li
Cheng Wei
Lin Luo
Shenghui Li
Junhu Zhou
Hao Liang
Ying Li
Lei Han

Frontiers in Oncology

doi 10.3389/fonc.2022.1055371

3,584 views
11 citations

Review

Published on 22 Dec 2022

Immune checkpoint blockade for locally advanced or recurrent/metastatic cervical cancer: An update on clinical data

in Cancer Immunity and Immunotherapy

Zhuo Song
Kun Zou
Lijuan Zou

Frontiers in Oncology

doi 10.3389/fonc.2022.1045481

13,129 views
13 citations

Case Report

Published on 22 Dec 2022

Case Report: Toxic epidermal necrolysis associated with sintilimab in a patient with relapsed thymic carcinoma

in Cancer Immunity and Immunotherapy

Huayu Yang
Qing Ma
Ying Sun
Kan Zhang
Yunli Xing
Hongwei Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1065137

2,372 views
12 citations

Original Research

Published on 22 Dec 2022

Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature

in Cancer Immunity and Immunotherapy

Wenhao Wang
Shan Hua
Jianying Li
Jing Zhao
Yu Zhang
Juntao Jiang
Bangmin Han

Frontiers in Oncology

doi 10.3389/fonc.2022.1081091

4,298 views
5 citations

Review

Published on 21 Dec 2022

Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC – A systematic review

in Cancer Immunity and Immunotherapy

Nikhil Samarth
Pooja Gulhane
Shailza Singh

Frontiers in Oncology

doi 10.3389/fonc.2022.1089320

6,241 views
10 citations

Original Research

Published on 20 Dec 2022

Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma

in Cancer Immunity and Immunotherapy

Hanzhang Liu
Tao Tao

Frontiers in Oncology

doi 10.3389/fonc.2022.1015850

2,356 views
3 citations

Original Research

Published on 20 Dec 2022

Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients

in Cancer Immunity and Immunotherapy

Javier David Benitez Fuentes
Kauzar Mohamed Mohamed
Alicia de Luna Aguilar
Carlos Jiménez García
Kissy Guevara-Hoyer
Miguel Fernandez-Arquero
M Antonia Rodríguez de la Peña
Laura Garciía Bravo
Alejandro Francisco Jiménez Ortega
Paloma Flores Navarro

Frontiers in Oncology

doi 10.3389/fonc.2022.975980

16,050 views
22 citations

Methods

Published on 19 Dec 2022

Spatial heterogeneity of cancer associated protein expression in immunohistochemically stained images as an improved prognostic biomarker

in Cancer Immunity and Immunotherapy

Henrik Failmezger
Harald Hessel
Ansh Kapil
Günter Schmidt
Nathalie Harder

Frontiers in Oncology

doi 10.3389/fonc.2022.964716

2,528 views
6 citations

Original Research

Published on 19 Dec 2022

Comparison of McKeown Minimally Invasive Esophagectomy vs sweet esophagectomy for esophageal squamous cell carcinoma: A retrospective study

in Cancer Immunity and Immunotherapy

Fan Yu
Yaozhong Zhang
Haidi Xu
Kuankuan Li
Jingge Gheng
Chenxi Lin
Lei Li
Na Wang
Lei Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1009315

2,393 views
5 citations

Review

Published on 12 Dec 2022

Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers

in Cancer Immunity and Immunotherapy

Nicholas J. Ede
Anthony J. Good
Joshua Tobias
Erika Garner-Spitzer
Christoph C. Zielinski
Ursula Wiedermann

Frontiers in Oncology

doi 10.3389/fonc.2022.939356

10,509 views
7 citations

Original Research

Published on 08 Dec 2022

Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis

in Cancer Immunity and Immunotherapy

Kang-Shuai Li
Sen Guo
Yu-Xin Chen
Zong-Li Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1075685

3,696 views
10 citations

Review

Published on 08 Dec 2022

The prospect of tumor microenvironment-modulating therapeutical strategies

in Cancer Immunity and Immunotherapy

Dirk Eulberg
Anna Frömming
Kfir Lapid
Aram Mangasarian
Avital Barak

Frontiers in Oncology

doi 10.3389/fonc.2022.1070243

5,058 views
19 citations

Case Report

Published on 08 Dec 2022

Acetylcholine receptor binding antibody–associated myasthenia gravis, myocarditis, and rhabdomyolysis induced by tislelizumab in a patient with colon cancer: A case report and literature review

in Cancer Immunity and Immunotherapy

Shengnan Wang
Danping Peng
Hao Zhu
Wanwan Min
Mengru Xue
Rui Wu
Yanqing Shao
Lin Pan
Mingqin Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.1053370

4,642 views
11 citations

Editorial

Published on 08 Dec 2022

Editorial: Immunotherapy for NSCLC with oncogenic driver variants

in Cancer Immunity and Immunotherapy

Yijia Du
Qian Chu
Yanyan Lou
Yong He
Hongbo Hu
Qipeng Hu
Meijuan Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.1095947

1,545 views

Case Report

Published on 07 Dec 2022

Case Report: Peripheral blood T cells and inflammatory molecules in lung cancer patients with immune checkpoint inhibitor-induced thyroid dysfunction: Case studies and literature review

in Cancer Immunity and Immunotherapy

Mona A. Marie
Justin D. McCallen
Zahra S. Hamedi
Abdul Rafeh Naqash
Alexander Hoffman
Druid Atwell
Suneetha Amara
Mahvish Muzaffar
Paul R. Walker
Li V. Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.1023545

2,866 views
2 citations

Original Research

Published on 07 Dec 2022

Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment

in Cancer Immunity and Immunotherapy

Songjiang He
Shi Zhang
Yi Yao
Bin Xu
Zhili Niu
Fuben Liao
Jie Wu
Qibin Song
Minglun Li
Zheming Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1064127

4,636 views
6 citations